Verve Therapeutics: A New Era in Cardiovascular Disease Treatment?
In a major breakthrough, Verve Therapeutics (VERV) has announced positive results from its Heart-2 clinical trial. This news sent shockwaves through the market, with shares surging by over 21% today. So what does this mean for investors? And is Verve Therapeutics a...